Dr. Martens PLC

AGM Information • Jul 29, 2021

National Storage Mechanism | Additional information

RNS Number : 9475G

Dr. Martens PLC

29 July 2021

29 July 2021

DR. MARTENS PLC

RESULT OF ANNUAL GENERAL MEETING

29 JULY 2021

The Company announces the results of voting at its Annual General Meeting held earlier today and confirms that all resolutions were duly passed on a poll with majorities as set out below.

Resolutions 1 to 15 were proposed as Ordinary Resolutions and resolutions 16 to 19 as Special Resolutions.

Resolution		Votes For	%	Votes Against	%	Votes Total	Votes Withheld	% Voting Capital Instructed
01	Receive the 2021 Annual Report and Accounts	817,208,045	100.00	918	0.00	817,208,963	286,712	81.72
02	Approve the Directors' Remuneration Report	814,391,695	99.62	3,102,787	0.38	817,494,482	1,193	81.75
03	Approve the Directors' Remuneration Policy	810,983,185	99.20	6,512,215	0.80	817,495,400	275	81.75
04	Re-elect Paul Mason	806,609,792	98.88	9,174,649	1.12	815,784,441	1,711,234	81.58
05	Re-elect Kenny Wilson	817,096,714	99.95	398,961	0.05	817,495,675	0	81.75
06	Re-elect Jon Mortimore	814,242,068	99.60	3,253,607	0.40	817,495,675	0	81.75
07	Re-elect Ian Rogers	817,494,757	100.00	918	0.00	817,495,675	0	81.75
08	Re-elect Ije Nwokorie	817,255,580	99.97	240,095	0.03	817,495,675	0	81.75
09	Re-elect Lynne Weedall	817,090,814	99.95	404,861	0.05	817,495,675	0	81.75
10	Re-elect Robyn Perriss	809,080,897	98.97	8,414,778	1.03	817,495,675	0	81.75
11	Re-elect Tara Alhadeff	808,826,724	98.94	8,668,033	1.06	817,494,757	918	81.75
12	Re-appoint Ernst & Young LLP as auditor	804,325,726	98.39	13,169,949	1.61	817,495,675	0	81.75
13	Authorise the Audit & Risk Committee to determine the Auditor's remuneration	812,881,504	99.44	4,613,253	0.56	817,494,757	918	81.75
14	Authorise the Company and its subsidiaries to make political donations	810,400,742	99.13	7,094,933	0.87	817,495,675	0	81.75
15	Authorise allotment of shares	785,256,734	96.06	32,238,941	3.94	817,495,675	0	81.75
16	Authorise general disapplication of pre-emption rights*	817,427,469	99.99	68,206	0.01	817,495,675	0	81.75
17	Authorise additional disapplication of pre-emption rights*	813,744,825	99.54	3,750,850	0.46	817,495,675	0	81.75
18	Authorise purchase of own shares*	817,175,338	99.99	100,592	0.01	817,275,930	219,745	81.73
19	Authorise calling of general meetings on 14 days' notice*	800,175,664	97.88	17,320,011	2.12	817,495,675	0	81.75

*Special Resolution

The votes of independent shareholders on the resolutions concerning the election or re-election of the Independent Non-Executive Directors are set out below:

Resolution		Votes For	%	Votes Against	%	Votes Total	Votes Withheld	% Independent Capital Instructed
07	Re-elect Ian Rogers	388,352,317	100.00%	918	0.00%	388,353,235	0	68.03
08	Re-elect Ije Nwokorie	388,113,140	99.94%	240,095	0.06%	388,353,235	0	68.03
09	Re-elect Lynne Weedall	387,948,374	99.90%	404,861	0.10%	388,353,235	0	68.03
10	Re-elect Robyn Perriss	379,938,457	97.83%	8,414,778	2.17%	388,353,235	0	68.03

Notes:

1.    Votes "For" and "Against" are expressed as a percentage of votes received.

2.    A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

3.    As at 6.30pm on 27 July 2021 the Company had a total of 1,000,000,100 ordinary shares with voting rights in issue. The total independent voting capital, used to calculate the votes of independent shareholders on resolutions 7-10, was 570,857,660.

4.    In accordance with Listing Rule 9.6.2R, copies of the resolutions passed as special business will shortly be available for inspection on the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.  

Enquiries

Investors and analysts                                                                  

Bethany Barnes, Director of Investor Relations                  +44 7825 187465

bethany.barnes@drmartens.com

Media                                                                                                                                                 

Finsbury Glover Hering

Rollo Head, James Leviton                                                           +44 20 7251 3801

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, "Docs" or "DMs" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. 

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGPPUWUMUPGGPB